ACT

OCTOBER 09/2018

news roundup

TrialScope Launches Clinical Trial Transparency Service

TrialScope, a company specializing in clinical trial transparency and compliance solutions, announced the launch of its Clinical Trial Transparency Service (CTTS) for sponsors. The new service hopes to improve patient engagement, lower costs, and increase transparency through a clinical trial publication website.

Advertisement

Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
Tuesday, November 6, 2018 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now


Catalent Selected to Provide Oral Delivery Systems

GB Sciences, Inc. and Catalent Pharma Solutions announced that GB Sciences has selected Catalent to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients for its Parkinson's disease therapies.


Advertisement

Identifying NASH Patients: Solutions and Strategies
Thursday, November 1, 2018, 11am EST
Register Now


Medidata and Decibel Therapeutics Announce Multi-Year Collaboration

Medidata announced that Decibel Therapeutics is adopting Medidata Cloud and specifically using its eTMF and eCOA/ePRO solutions. The agreement will support Decibel Therapeutics' clinical development for hearing loss, tinnitus, and balance disorders.


Advertisement

A Pan-cancer View of Immune Cell Activity, Immune Checkpoints, and Tumor Mutational Burden
Thursday, October 11, 2018 at 11am EDT
Register Now


ActiGraph Launches New Activity Monitor

ActiGraph has announced the launch of its newest activity monitor, the CentrePoint Insight Watch. This watch hopes to deliver high quality, real-world data, and an enhance patient experiences during clinical drug trials and health research studies.


Advertisement

On the brink of change: How academic data and machine learning can revolutionize Alzheimer's drug development
On Demand
Learn More

In this edition

ActiGraph Launches New Activity Monitor
Comparing Risk Based Monitoring and Remote Trial Management vs. SDV
An Introduction to BYOD: What You Need to Know in a Snapshot
Pediatric Oncology Clinical Trials in Sub-Saharan Africa

Advertisement

Research Reveals Data Quality Issues Slow Clinical Trial Progression – What Can You Do To Prevent This?
On Demand
Learn more


Events

Rare Diseases & Orphan Products Breakthrough Summit
Basket and Umbrella Trials for Oncology
IRT 2018
eCOA / ePRO 2018
Women of Color in Pharma Second Annual Conference
2018 HBA Annual Conference
Search Upcoming Events

Advertisement

Artificial Intelligence: A Transformative Journey for Pharmacovigilance
On Demand
Learn More


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Advertisement

Challenging the Status Quo: The Diffusion of Technology in Study Startup
On Demand
Learn More


Articles

Medical Coding Procedures in Clinical Research: An Amarex Safety and Pharmacovigilance Perspective

This article will detail how the Amarex Safety & Pharmacovigilance team performs medical coding using an internally developed safety platform.


Advertisement

A Next Generation Sequencing Approach to Influenza Vaccine Development
On Demand
Learn More


Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.

Blog Posts

An Introduction to BYOD: What You Need to Know in a Snapshot

Researchers are now looking to design their trials around a bring-your-own-device (BYOD) strategy, which allows participants in a clinical trial to provide study data using their own internet-enabled hardware.


Advertisement

Decoding the Distinction: DMCs, CECs, and Their Role in Medical Device Research
On Demand
Learn more


FDA Supports Streamlined Trials for New Antimicrobials

The critical need for new medicines to combat infectious diseases is prompting FDA to join with other federal health agencies and the biomedical research community to advance the science, regulatory policies, and reimbursement strategies to promote innovation in this area.

Oncology

Pediatric Oncology Clinical Trials in Sub-Saharan Africa

The region is significantly underrepresented in clinical development activity targeting childhood cancer.

Master Protocols in Oncology: A Review of the Landscape

With technology's increasing ability to gather and analyze previously unmanageable data sets, and medicine's forays into genomics and targeted therapies, the time of the master protocol may be at hand.

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com